Siamak Daneshmand

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah et al. · Nature · 2021 · 578 citations

Adjuvant Immunotherapy, Cancer Immunosurveillance, Urology +1

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

Joaquim Bellmunt, Maha Hussain, Jürgen E. Gschwend et al. · The Lancet Oncology · 2021 · 393 citations · Full text

Urology, Versus Observation, Genitourinary Cancer +6

Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active Surveillance

Christian Kollmannsberger, Torgrim Tandstad, Philippe L. Bédard et al. · Journal of Clinical Oncology · 2014 · 342 citations

PROGNOSIS OF PATIENTS WITH LYMPH NODE POSITIVE PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: LONG-TERM RESULTS

Siamak Daneshmand, Marcus L. Quek, John P. Stein et al. · The Journal of Urology · 2004 · 315 citations

Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Homayoun Zargar, Patrick Espiritu, Adrian Fairey et al. · European Urology · 2014 · 296 citations · Full text

Urology, Genitourinary Cancer, Medicine +2